In addition to ANP, BNP, and neprilysin, CNP could play a role in modulation of cGMP/PKG signaling pathways via CNP/pGC/cGMP route, thus representing a potential therapeutic target for the treatment of IHD. This evidence concerns the gene PRKG1 and myocardial ischemia.